Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3703, Durham, NC 27710
Phone (919) 681-6386
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine/Nephrology, Vice Chair for Faculty Development and Diversity in the Department of Medicine, and School of Medicine Faculty Ombudsperson. She is also the Director of Duke’s CTSA-sponsored internal career development award program (KL2) and the Investigator Development Core of Duke’s REACH Equity Disparities Research Center.

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is an American Society of Hypertension certified hypertension specialist, and a member of the Association of American Physicians (AAP). She is the Associate Director, Core Director and Project PI of Duke’s REACH Equity Disparities Research Center.

As Department of Medicine Vice Chair for Faculty Development and Diversity, she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

As School of Medicine Faculty Ombudsperson, she helps faculty resolve concerns by providing confidential, impartial, informal guidance.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Moore, T. J., P. R. Conlin, J. Ard, and L. P. Svetkey. “DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension..” Hypertension 38, no. 2 (August 2001): 155–58. https://doi.org/10.1161/01.hyp.38.2.155.

PMID
11509468
Full Text

Alderman, M. “Dietary sodium and blood pressure..” N Engl J Med 344, no. 22 (May 31, 2001).

PMID
11386274
Scholars@Duke

Sacks, F. M., M. A. Porschan, and L. P. Svetkey. “Dietary sodium and blood pressure. Reply.” New England Journal of Medicine 344, no. 22 (May 31, 2001): 1718–19.

Scholars@Duke

Sacks, F. M., L. P. Svetkey, W. M. Vollmer, L. J. Appel, G. A. Bray, D. Harsha, E. Obarzanek, et al. “Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group..” N Engl J Med 344, no. 1 (January 4, 2001): 3–10. https://doi.org/10.1056/NEJM200101043440101.

PMID
11136953
Full Text

Vollmer, William M., Frank M. Sacks, and Laura P. Svetkey. “New insights into the effects on blood pressure of diets low in salt and high in fruits and vegetables and low-fat dairy products..” Curr Control Trials Cardiovasc Med 2, no. 2 (2001): 71–74. https://doi.org/10.1186/cvm-2-2-071.

PMID
11806776
Full Text

Appel, L. J., P. R. Conlin, D. W. Harsha, G. T. Meltesen, S. R. Mitchell, T. J. Moore, F. M. Sacks, and L. P. Svetkey. “A clinical trial of the effects of sodium reduction and the DASH diet on ambulatory blood pressure: Results from the DASH-sodium feeding study.” Circulation 102, no. 18 (October 31, 2000): 416–416.

Scholars@Duke

Miller, E. R., T. P. Erlinger, A. D. Bohannon, P. H. Lin, L. P. Svetkey, F. M. Sacks, and L. J. Appel. “The effects of dietary patterns on antibodies to oxidized LDL: Results from a randomized clinical trial.” Circulation 102, no. 18 (October 31, 2000): 82–82.

Scholars@Duke

Appel, L. J., J. Charleston, P. R. Conlin, T. P. Erlinger, D. W. Harsha, E. R. Miller, T. J. Moore, and L. P. Svetkey. “The effect of race on circadian patterns of blood pressure: results from the dietary approaches to stop hypertension (DASH) feeding study.” Hypertension 36, no. 4 (October 1, 2000): 715–715.

Scholars@Duke

Conlin, P. R., D. Chow, E. R. Miller, L. P. Svetkey, P. H. Lin, D. W. Harsha, T. J. Moore, F. M. Sacks, and L. J. Appel. “The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial..” Am J Hypertens 13, no. 9 (September 2000): 949–55. https://doi.org/10.1016/s0895-7061(99)00284-8.

PMID
10981543
Full Text

Pages